DalsnaFinance

AbbVie (ABBV) Reaches 52-Week High Amid Proposed Changes to Drug Pricing Program

Stocks GuruFocus By GuruFocus 02 Jul 2026 17:09 1 min read
AbbVie (ABBV) Reaches 52-Week High Amid Proposed Changes to Drug Pricing Program

AbbVie (ABBV) Reaches 52-Week High Amid Proposed Changes to Drug Pricing Program  GuruFocus

AbbVie (ABBV) Reaches 52-Week High Amid Proposed Changes to Drug Pricing Program GuruFocus

Read the full story on GuruFocus → Opens the original article on news.google.com

Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.